S Boivin

475 total citations
9 papers, 277 citations indexed

About

S Boivin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, S Boivin has authored 9 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 2 papers in Genetics. Recurrent topics in S Boivin's work include Diabetes Management and Research (7 papers), Pancreatic function and diabetes (3 papers) and Diabetes Treatment and Management (3 papers). S Boivin is often cited by papers focused on Diabetes Management and Research (7 papers), Pancreatic function and diabetes (3 papers) and Diabetes Treatment and Management (3 papers). S Boivin collaborates with scholars based in France, Norway and Canada. S Boivin's co-authors include N. Jeandidier, Bruno Guerci, Éric Renard, V. Melki, Laurent Meyer, B. Augendre‐Ferrante, V. Lassmann‐Vague, J. Tauber, H Hanaire-Broutin and P. Bélicar and has published in prestigious journals such as Diabetes Care, Advanced Drug Delivery Reviews and Diabetologia.

In The Last Decade

S Boivin

9 papers receiving 265 citations

Peers

Countries citing papers authored by S Boivin

Since Specialization

Citations

This map shows the geographic impact of S Boivin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Boivin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Boivin more than expected).

Fields of papers citing papers by S Boivin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Boivin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Boivin. The network helps show where S Boivin may publish in the future.

Co-authorship network of co-authors of S Boivin

This figure shows the co-authorship network connecting the top 25 collaborators of S Boivin. A scholar is included among the top collaborators of S Boivin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Boivin. S Boivin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Evaluation of the effectiveness of arsenic screening promotion in private wells: a quasi-experimental study 2011 ·Health Promotion International ·(unknown), F Gagnon, Cécile Michaud, S Boivin	21
2	Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience 2003 ·Diabetes & Metabolism ·H. Gin, Éric Renard, V. Melki, S Boivin, P Schaepelynck-Bélicar, Bruno Guerci, (unknown), (unknown), (unknown), Bruno Estour, Bogdan Catargi	50
3	[Insulinoma with hyperproinsulinemia: a two cases report]. 2002 ·PubMed ·(unknown), (unknown), (unknown), S Boivin	5
4	Macrophage Activation in Type 1 Diabetic Patients With Catheter Obstruction During Peritoneal Insulin Delivery With an Implantable Pump 2001 ·Diabetes Care ·Laurence Kessler, (unknown), A. Bohbot, S. Sigrist, (unknown), S Boivin, P. Dufour, A. Belcourt, M. Pinget	12
5	Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment1Abbreviations: AIA, antiinsulin antibody; CAPD, continuous ambulatory dialysis; CSII, continuous subcutaneous insulin infusion; DCCT, diabetes control complications trial; FIR, far infrared radiation; GLP1, glucagon-like peptide 1; GH, growth hormone; HbA1c, glycated hemoglobin; IDDM, insulin-dependent diabetes mellitus; IGF1, insulin-like growth factor 1; i.p., intraperitoneal; ISF, interstitial fluid; ISGIID, International Study Group on Implantable Insulin Delivery Devices; i.v., intravenous; MDI, multiple daily injections; NIDDM, non-insulin-dependent diabetes mellitus; PAI1, plasminogen activator inhibitor 1; rh IGF1, recombinant human insulin-like growth factor 1; SHBG, sex hormone binding globulin; SC, subcutaneous; SMBG, self monitoring of blood glucose; TG, triglycerides.1 1999 ·Advanced Drug Delivery Reviews ·N. Jeandidier, S Boivin	38
6	Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps 1998 ·Diabetes Care ·V. Melki, Éric Renard, V. Lassmann‐Vague, S Boivin, Bruno Guerci, H Hanaire-Broutin, J. Bringer, P. Bélicar, N. Jeandidier, Laurent Meyer, Patrick Blin, B. Augendre‐Ferrante, J. Tauber	115
7	Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices 1995 ·Diabetologia ·N. Jeandidier, S Boivin, R Sapin, (unknown), B. Uring‐Lambert, (unknown), M. Pinget	33
8	[A promising alternative for the treatment of type I diabetes. The implantable insulin pump]. 1995 ·PubMed ·Jacques Marescaux, (unknown), Didier Mutter, N. Jeandidier, S Boivin, M. Pinget	1
9	[Implantable insulin pump: the first step towards an artificial pancreas]. 1994 ·PubMed ·(unknown), Didier Mutter, N. Jeandidier, S Boivin, M. Pinget, Jacques Marescaux	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact